Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Rhabdomyolysis, Urinary tract infection
Clinical narrative: rhabdomyolysis; very bad UTI; Renal disorder; unable to walk; problem with her heart; Fall; passing out that evening; This spontaneous case was reported by a consumer and describes the occurrence of LOSS OF CONSCIOUSNESS (passing out that evening), RHABDOMYOLYSIS (rhabdomyolysis) and URINARY TRACT INFECTION (very bad UTI) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included LOSARTAN, POTASSIUM, CALCIUM, FISH OIL, ROSUVASTATIN and VITAMINS NOS for an unknown indication.    On 05-Oct-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Oct-2021, the patient experienced LOSS OF CONSCIOUSNESS (passing out that evening) (seriousness criterion medically significant). On an unknown date, the patient experienced RHABDOMYOLYSIS (rhabdomyolysis) (seriousness criterion medically significant), URINARY TRACT INFECTION (very bad UTI) (seriousness criterion medically significant), RENAL DISORDER (Renal disorder), GAIT INABILITY (unable to walk), CARDIAC DISORDER (problem with her heart) and FALL (Fall). The patient was treated with HEPARIN for Embolism, at an unspecified dose and frequency. At the time of the report, LOSS OF CONSCIOUSNESS (passing out that evening) and FALL (Fall) had resolved, RHABDOMYOLYSIS (rhabdomyolysis), URINARY TRACT INFECTION (very bad UTI), RENAL DISORDER (Renal disorder) and CARDIAC DISORDER (problem with her heart) outcome was unknown and GAIT INABILITY (unable to walk) had not resolved.            patient went into a nursing home for 20 days. She has nurses and a physical therapist at her home They are trying to rule out a minor myocardial infarction. She had a very bad UTI that she was put on IV medication for treatment. She Planned for checkup with Neurologist, cardiologist and her primary care provider for her fall. Patient legs aren't still were they need to be. She had none of these medical conditions prior to getting the Moderna COVID-19 vaccination.   This is a spontaneous case concerning a 75-year-old female patient with no reported medical history, taking rosuvastatin, losartan and vitamins for unknown indication, who experienced the serious  unexpected events loss of consciousness, rhabdomyolysis, urinary tract infection and non serious renal disorder and cardiac disorder. Loss of consciousness occurred on the next day and rest of the events occurred on an unknown day after the second  dose of mRNA-1273 Moderna vaccine.  Concomitant medication Rosuvastatin could be a  a potentially co-suspect for event rhabdomyolysis. Further information is not expected, as patient did not give consent for safety follow-up. The benefit-risk relationship of mRNA-1273 Moderna vaccine is not affected by this report.   Reporter did not allow further contact; Sender's Comments: This is a spontaneous case concerning a 75-year-old female patient with no reported medical history, taking rosuvastatin, losartan and vitamins for unknown indication, who experienced the serious  unexpected events loss of consciousness, rhabdomyolysis, urinary tract infection and non serious renal disorder and cardiac disorder. Loss of consciousness occurred on the next day and rest of the events occurred on an unknown day after the second  dose of mRNA-1273 Moderna vaccine.  Concomitant medication Rosuvastatin could be a  a potentially co-suspect for event rhabdomyolysis. Further information is not expected, as patient did not give consent for safety follow-up. The benefit-risk relationship of mRNA-1273 Moderna vaccine is not affected by this report.